Inflammatory Responses Completed Phase 4 Trials for Methylprednisolone (DB00959)

Also known as: Inflammatory Response

IndicationStatusPhase
DBCOND0062877 (Inflammatory Responses)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00968578Effects of Methylprednisolone After Total Knee ArthroplastySupportive Care
NCT00968903Effects of Methylprednisolone After Total Hip ArthroplastySupportive Care